BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26401944)

  • 1. 30-Day Mortality after Cardiovascular Events in Persons with or without Alzheimer's Disease.
    Heiskanen J; Hartikainen S; Roine RP; Tolppanen AM
    J Alzheimers Dis; 2015; 48(1):241-9. PubMed ID: 26401944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incident ischaemic heart disease in persons with Alzheimer's disease in a Finnish nationwide exposure-matched cohort.
    Tolppanen AM; Kettunen R; Ahonen R; Soininen H; Hartikainen S
    Int J Cardiol; 2013 Dec; 170(2):195-201. PubMed ID: 24200309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of stroke in people with Alzheimer disease: a national register-based approach.
    Tolppanen AM; Lavikainen P; Solomon A; Kivipelto M; Soininen H; Hartikainen S
    Neurology; 2013 Jan; 80(4):353-8. PubMed ID: 23284063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbleeds, Mortality, and Stroke in Alzheimer Disease: The MISTRAL Study.
    Benedictus MR; Prins ND; Goos JD; Scheltens P; Barkhof F; van der Flier WM
    JAMA Neurol; 2015 May; 72(5):539-45. PubMed ID: 25798556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of predictors of hip fracture and mortality after hip fracture in community-dwellers with and without Alzheimer's disease - exposure-matched cohort study.
    Tolppanen AM; Taipale H; Tanskanen A; Tiihonen J; Hartikainen S
    BMC Geriatr; 2016 Dec; 16(1):204. PubMed ID: 27908278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of death among persons with Alzheimer's disease: a national register-based nested case-control study.
    Lönnroos E; Kyyrönen P; Bell JS; van der Cammen TJ; Hartikainen S
    J Alzheimers Dis; 2013; 33(1):157-64. PubMed ID: 22914589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of β-blocker therapy with risks of adverse cardiovascular events and deaths in patients with ischemic heart disease undergoing noncardiac surgery: a Danish nationwide cohort study.
    Andersson C; Mérie C; Jørgensen M; Gislason GH; Torp-Pedersen C; Overgaard C; Køber L; Jensen PF; Hlatky MA
    JAMA Intern Med; 2014 Mar; 174(3):336-44. PubMed ID: 24247428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of cardiovascular events and mortality among a population-based cohort of immigrants and long-term residents with diabetes: Are all immigrants healthier and if so, for how long?
    Okrainec K; Bell CM; Hollands S; Booth GL
    Am Heart J; 2015 Jul; 170(1):123-32. PubMed ID: 26093873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stroke after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction: timing, characteristics, and clinical outcomes.
    Guptill JT; Mehta RH; Armstrong PW; Horton J; Laskowitz D; James S; Granger CB; Lopes RD
    Circ Cardiovasc Interv; 2013 Apr; 6(2):176-83. PubMed ID: 23549644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of Mortality Associated with Antipsychotic Monotherapy and Polypharmacy Among Community-Dwelling Persons with Alzheimer's Disease.
    Koponen M; Taipale H; Lavikainen P; Tanskanen A; Tiihonen J; Tolppanen AM; Ahonen R; Hartikainen S
    J Alzheimers Dis; 2017; 56(1):107-118. PubMed ID: 27935554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of head and traumatic brain injuries associated with antidepressant use among community-dwelling persons with Alzheimer's disease: a nationwide matched cohort study.
    Taipale H; Koponen M; Tanskanen A; Lavikainen P; Sund R; Tiihonen J; Hartikainen S; Tolppanen AM
    Alzheimers Res Ther; 2017 Aug; 9(1):59. PubMed ID: 28764750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of death associated with new benzodiazepine use among persons with Alzheimer disease: A matched cohort study.
    Saarelainen L; Tolppanen AM; Koponen M; Tanskanen A; Tiihonen J; Hartikainen S; Taipale H
    Int J Geriatr Psychiatry; 2018 Apr; 33(4):583-590. PubMed ID: 29143367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of benzodiazepines and related drugs is associated with a risk of stroke among persons with Alzheimer's disease.
    Taipale H; Koponen M; Tanskanen A; Lavikainen P; Tolppanen AM; Sund R; Tiihonen J; Hartikainen S
    Int Clin Psychopharmacol; 2017 May; 32(3):135-141. PubMed ID: 28072593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hospital admissions, outpatient visits and healthcare costs of community-dwellers with Alzheimer's disease.
    Tolppanen AM; Taipale H; Purmonen T; Koponen M; Soininen H; Hartikainen S
    Alzheimers Dement; 2015 Aug; 11(8):955-63. PubMed ID: 25496872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incident hip fractures among community dwelling persons with Alzheimer's disease in a Finnish nationwide register-based cohort.
    Tolppanen AM; Lavikainen P; Soininen H; Hartikainen S
    PLoS One; 2013; 8(3):e59124. PubMed ID: 23527106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of comorbidities on survival in persons with Alzheimer's disease: a matched cohort study.
    Rajamaki B; Hartikainen S; Tolppanen AM
    BMC Geriatr; 2021 Mar; 21(1):173. PubMed ID: 33750334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipsychotic polypharmacy among a nationwide sample of community-dwelling persons with Alzheimer's disease.
    Taipale H; Koponen M; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S
    J Alzheimers Dis; 2014; 41(4):1223-8. PubMed ID: 24787914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiepileptic Drug Use and the Risk of Stroke Among Community-Dwelling People With Alzheimer Disease: A Matched Cohort Study.
    Sarycheva T; Lavikainen P; Taipale H; Tiihonen J; Tanskanen A; Hartikainen S; Tolppanen AM
    J Am Heart Assoc; 2018 Sep; 7(18):e009742. PubMed ID: 30371186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hospital care and drug costs from five years before until two years after the diagnosis of Alzheimer's disease in a Finnish nationwide cohort.
    Taipale H; Purhonen M; Tolppanen AM; Tanskanen A; Tiihonen J; Hartikainen S
    Scand J Public Health; 2016 Mar; 44(2):150-8. PubMed ID: 26553247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.